[{"NetIncomeLoss_1_Q3_USD":-33804000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":9376775.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1_Q3_pure":0.5,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_3_Q3_pure":0.5,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":255902000.0,"AssetsCurrent_0_Q3_USD":327687000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1160000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":1121000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-140000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1920540.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":6000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":123804000.0,"Depreciation_3_Q3_USD":578000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-43727000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":51500000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-207000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":27600000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":3944000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2744000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2632000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":855000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":21.92,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":123995000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1381000.0,"OtherAccountsPayableAndAccruedLiabilities_0_Q3_USD":33061000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5371000.0,"ShareBasedCompensation_3_Q3_USD":11371000.0,"Assets_0_Q3_USD":373175000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":212000.0,"CommonStockSharesIssued_0_Q3_shares":47671654.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":213080000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":16.6,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-204000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":17.54,"AccruedLiabilitiesCurrent_0_Q3_USD":33061000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":4722000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-33949000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-88876000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":127750000.0,"CommonStockValue_0_Q3_USD":null,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":120542000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-148000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":7120000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":17.54,"ResearchAndDevelopmentExpense_1_Q3_USD":36956000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":87633000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":556000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-136000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":4238000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":702319000.0,"Liabilities_0_Q3_USD":43515000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"DueFromRelatedPartiesCurrent_0_Q3_USD":2638000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":47987184.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":45705782.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7256000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":19936000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":12.89,"MarketableSecuritiesCurrent_0_Q3_USD":193759000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseLiability_0_Q3_USD":6265000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-5000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-25000.0,"DefinedContributionPlanCostRecognized_1_Q3_USD":100000.0,"DefinedContributionPlanCostRecognized_3_Q3_USD":300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":3944000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":-2285000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-12236000.0,"CommonStockSharesAuthorized_0_Q3_shares":90000000.0,"OperatingIncomeLoss_1_Q3_USD":-33926000.0,"LiabilitiesCurrent_0_Q3_USD":39156000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":2660000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":38169000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-80926000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_3_Q3_USD":-1611000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4775000.0,"AccountsPayableCurrent_0_Q3_USD":706000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":11371000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-88644000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_1_Q3_USD":3500.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount_3_Q3_USD":3500.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-145000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-232000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":6083955.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-33804000.0,"RestrictedCashNoncurrent_0_Q3_USD":225000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":120767000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":791000.0,"NetIncomeLoss_3_Q3_USD":-88644000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1723000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":18700000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":24000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"OperatingLeasePayments_3_Q3_USD":1493000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8877000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":116068000.0,"SubleaseIncome_3_Q3_USD":68000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":27600000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.096,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q3_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":308125.0,"CommonStockSharesOutstanding_0_Q3_shares":47671654.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":2949000.0,"LeaseCost_3_Q3_USD":1310000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":373175000.0,"OperatingLeaseCost_3_Q3_USD":1378000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.87,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":29.93,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":2241000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"InvestmentIncomeInterest_1_Q3_USD":122000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":854000.0,"IncomeTaxesReceivable_0_Q3_USD":1871000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_1_Q3_USD":200000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_3_Q3_USD":1700000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_3_Q3_shares":176580.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":14393000.0,"InvestmentIncomeInterest_3_Q3_USD":321000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":11371000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4775000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2027000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-372455000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":3121045.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6083955.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":10286000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":18740000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1321000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":905000.0,"StockholdersEquity_0_Q3_USD":329660000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":121000.0,"ProfitLoss_3_Q3_USD":-88644000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.7,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.94,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1373000.0,"OperatingExpenses_1_Q3_USD":44212000.0,"OperatingExpenses_3_Q3_USD":107569000.0,"OperatingIncomeLoss_3_Q3_USD":-88829000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1566000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211103"}]